Identity confirmed with an official business registry. How we verify
Pulmonx has developed the Zephyr Endobronchial Valve Therapy, a minimally invasive treatment for emphysema, a form of COPD. The Zephyr Valve is a bronchoscopic treatment for patients with severe COPD/emphysema, performed without surgery and its associated risks. Clinical findings are consistent across four randomized control trials. The procedure reduces hyperinflation, an underlying cause of breathlessness in these patients.
Description based on the company's website.
Official data
- Registry
- SEC EDGAR (États-Unis)
- Number
- 0001127537
- Legal name
- Pulmonx Corp
- Verified on
Products manufactured
Product illustrations, until the company adds its own photos.
The factor-by-factor breakdown, the comparison of your suppliers and alerts are reserved for buyer accounts. See the details and compare
Request a quote
Contact via Tritonis: the Tritonis team forwards your request to Pulmonx and follows it up until it gets a reply. It also goes right away to the other suppliers ticked below. Indicative forwarding time: 5 business days.
Other suppliers: Medical and dental instruments
-
Aesculap, Inc.Main product at 0% Canadian duty
See all suppliers of this product
Spotted an error on this listing?
Report it: we review every report, usually within two business days. No account is needed.
Recently viewed





